Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

News > All

Total search results: 16865 | Ordered by Source (descending)
1 2 3 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
–. (4/2/09). "Press Release: Wirtschaftsbehörde. 500.000 Euro für Forschungsprojekt der Eppendorf AG". 2009-04-02
[iito] Business Intelligence. (9/29/11). "[iito]view – E-mail Interview with Pierre Legrain, Vice President of HUPO". Bremen. 2011-09-29
[iito] Business Intelligence. (9/15/10). "Press Release: [iito] Announces Milestones for Mass Spectrometry Web Portal »Mass-Spec-Capital.com«. Opens Newsletter Archives – Launches Own Editorial Content". Bremen. 2010-09-15
[iito] Business Intelligence. (5/23/11). "Press Release: Launch of Life-Sciences-Germany.com – English-language Doorway to Life Sciences in German-speaking Europe". Bremen. 2011-05-23
[iito] Business Intelligence. (5/20/10). "Press Release: [iito] Launches Free Mass Spectrometry Newsletter. Premier Issue Right in Time for ASMS 2010 Meeting in Salt Lake City – New Service Is Based on the Web Portal www.Mass-Spec-Capital.com". Bremen. 2010-05-20
[iito] Business Intelligence. (3/5/10). "Press Release: Launch of New Mass Spectrometry Web Portal – Mass-Spec-Capital.com". Bremen. 2010-03-05
[iito] Business Intelligence. (3/24/11). "Press Release: [iito] Business Intelligence Enters Social Media with an Initial Focus on Twitter. Strategic Move Positions [iito] in the Up-to-the-Minute News Market for Mass Spectrometry as well as German and Eu 2011-03-24
[iito] Business Intelligence. (12/9/15). "Press Release: Life-Sciences-UK.com Launches Today. New Business Web Portal for the UK and Irish Life Sciences Targets Decision Makers World-wide". Bremen & London. 2015-12-09
[iito] Business Intelligence. (11/7/11). "Press Release: [iito] Completes Online B2B Offering with Launch of Free Newsletter for the European Life Sciences. Premier Issue of the [LSE] Newsletter Published Today". Bremen. 2011-11-07
[iito] Business Intelligence. (10/6/11). "Press Release: [iito] Launches Free Monthly Newsletter for the Life Sciences in Germany, Austria and Switzerland. Premier Issue of the [LSG] Newsletter Published Today". Bremen. 2011-10-06
[iito] Business Intelligence. (10/5/15). "Press Release: Life-Sciences-France.com Launches Today. New Business Web Portal for the French Life Sciences Targets Decision Makers Worldwide". Bremen & Paris. 2015-10-05
[iito] Business Intelligence. (10/4/12). "Press Release: [iito] Is Putting Privacy and Content First. Free [iito] Web Offerings Target Senior-level Managers in the Worldwide Life Sciences Industry". Bremen. 2012-10-04
[iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2018-10-31
[iito] Business Intelligence. (10/11/11). "Press Release: Life-Sciences-Europe.com Launches Today. Business Web Portal for the European Life Sciences". Bremen. 2011-10-11
Zytoprotec GmbH. (1/29/13). "Press Release: Zytoprotec Raises EUR 2 Million in Financing from Baxter Ventures". Vienna. 2013-01-29
Zymeworks Inc.. (4/26/16). "Press Release: Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies". Vancouver. 2016-04-26
Zymeworks Inc.. (12/3/15). "Press Release: Zymeworks Announces Antibody Fc Engineering Collaboration and License Agreement with GSK". Vancouver. 2015-12-03
Zyme Communications Ltd.. (9/24/14). "Press Release: Zyme Communications Wins Eight New Clients and Expands Team". 2014-09-24
Zyme Communications Ltd.. (8/1/17). "Press Relase: Zyme Communications Strengthens Team and Relocates Cambridge Office". Cambridge. 2017-08-01
Zyme Communications Ltd.. (12/20/12). "Press Release: Zyme Communications Ends 2012 with Five New Client Wins". 2012-12-20
ZyGEM Corporation Ltd.. (3/26/09). "Press Release: ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe. Extends Successful Existing Distribution Agreement for the Americas". Solana B 2009-03-26
Zivak Technologies. (10/3/13). "Press Release: Introduction of SPE9600 Automated 96-Well-Plate SPE System at Medica 2013 Fair". 2013-10-03
Zivak Technologies. (10/2/13). "Press Release: ZinMass Clinical LC-MS/MS Analyzer Will Be Exhibited at Medica 2013". 2013-10-02
Zinc Ahead Ltd.. (9/29/15). "Press Release: Veeva Systems Acquires Zinc Ahead. Leading Providers Join to Deliver the Most Complete Commercial Content Management Solution for the Life Sciences Industry". Pleasanton, CA & Oxford. 2015-09-29
Ziarco Pharma Ltd.. (6/13/16). "Press Release: Ziarco Reports Positive Phase 2a Study Results with ZPL-389 in Moderate to Severe Atopic Dermatitis Patients". Discovery Park, Sandwich. 2016-06-13
Ziarco Pharma Ltd.. (3/18/13). "Press Release: Dr John LaMattina Joins Ziarco as Strategic Advisor". Canterbury. 2013-03-18
Ziarco Pharma Ltd.. (2/29/16). "Press Release: Ziarco Appoints Dr. Arvind Hundal as Chief Business Officer". Discovery Park, Sandwich. 2016-02-29
Ziarco Pharma Ltd.. (11/5/12). "Press Release: Ziarco Secures Series A Funding". Canterbury. 2012-11-05
Ziarco Pharma Ltd.. (11/10/14). "Press Release: Ziarco Raises $33.1 Million in Series B Financing". Canterbury. 2014-11-10
Zenith Technologies. (8/19/16). "Press Release: Pharma Tech Firm Expands US Presence". 2016-08-19
Zeltia S.A.. (9/15/15). "Press Release: PharmaMar Opens New Affiliate in UK". Madrid. 2015-09-15
Zeltia S.A.. (9/1/15). "Press Release: Pharmaceutical Council Recommends Approval of Yondelis (trabectedin) in Japan". Madrid. 2015-09-01
Zeltia S.A.. (8/20/15). "Press Release: PharmaMar Announces License Agreement with Specialised Therapeutics Australia Pty for Aplidin (plitidepsin) in Oncology". Madrid. 2015-08-20
Zeltia S.A.. (7/31/15). "Press Release: PharmaMar Passes the U.S. FDA Manufacturing Inspection for Yondelis Active Ingredient". Madrid. 2015-07-31
Zeltia S.A.. (7/28/15). "Press Release: Grupo Zeltia Reports First Half 2015 Financial Results". Madrid. 2015-07-28
Zeltia S.A.. (7/23/15). "Press Release: PharmaMar Announces License Agreement with TTY Biopharm for Aplidin (plitidepsin) in Hematological Cancers". Madrid. 2015-07-23
Zeltia S.A.. (7/23/14). "Press Release: PharmaMar Initiates a Phase I Study with Aplidin in Combination with Bortezomib and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma". Madrid. 2014-07-23
Zeltia S.A.. (7/23/12). "Press Release: Report at 30 June 2012. 1H12 Highlights". Madrid. 2012-07-23
Zeltia S.A.. (7/22/15). "Press Release: Genomica and the Foundation for Excellence and Quality in Oncology Announce a Framework Agreement for Collaboration in Oncology". Madrid. 2015-07-22
Zeltia S.A.. (7/2/12). "Press Release: Zeltia Announces that Subsidiary PharmaMar Is Commencing a Phase II Trial with PM01183 in Patients with Breast Cancer". Madrid. 2012-07-02
Zeltia S.A.. (7/17/14). "Press Release: Sylentis Receives Authorisation to Commence Phase IIb Clinical Trial with Bamosiran (SYL040012) for Treating Ocular Hypertension Associated with Glaucoma". Madrid. 2014-07-17
Zeltia S.A.. (6/29/15). "Press Release: PharmaMar Initiates the Phase III Study CORAIL for the Anticancer Agent PM1183 in Patients with Platinum-resistant Ovarian Cancer". Madrid. 2015-06-29
Zeltia S.A.. (6/29/12). "Press Release: Zeltia Receives 9.5 Million Euro from the Spanish Public Administrations for the Payment of Outstanding Invoices". Madrid. 2012-06-29
Zeltia S.A.. (3/20/13). "Press Release: Genomica Develops New Diagnostic Kits for Somatic Mutations that Are Determinant in Anti-tumour Therapies". Madrid. 2013-03-20
Zeltia S.A.. (2/3/15). "Press Release: U.S. FDA Grants Priority Review to Yondelis NDA for Advanced Soft-tissue Sarcoma". Madrid. 2015-02-03
Zeltia S.A.. (2/28/14). "Press Release: Zeltia Net Profit Soars 72%. Reported EBITDA of 23.8 Million Euros Increased by 16.6%". Madrid. 2014-02-28
Zeltia S.A.. (2/28/13). "Press Release: Zeltia Posts Net Attributable Profit of €6.6 Million (+39%)". Madrid. 2013-02-28
Zeltia S.A.. (2/27/13). "Press Release: Zeltia Announces that Subsidiary Sylentis Has Commenced Phase II Clinical Trials with Compound SYL1001 for Treating Eye Discomfort Associated with Dry Eye Syndrome". Madrid. 2013-02-27
Zeltia S.A.. (2/26/15). "Press Release: Zeltia's Board of Directors Will Propose to the Next Shareholders' Meeting that Pharma Mar Merge with and Absorb Its Parent Company, Zeltia. The Board of Directors Will also Request that Pharma Mar Seek an IPO in 2015-02-26
Zeltia S.A.. (2/26/15). "Press Release: Grupo Zeltia Net Attributable Profit Amounted to 13 Million Euro in 2014 (+16%). Group Total Revenues Amounted to 178 Million Euro (+8%).". Madrid. 2015-02-26
Zeltia S.A.. (12/2/14). "Press Release: Zeltia Announces that Its Board of Directors Has Approved a Strategy to Explore Merging PharmaMar and Zeltia in Advance of a Listing Request in the US". Madrid. 2014-12-02
Zeltia S.A.. (11/7/12). "Press Release: PharmaMar Germany Commences Commercial Activity". Madrid. 2012-11-07
Zeltia S.A.. (11/25/14). "Press Release: PharmaMar Announces that Its Partner Janssen Has Submitted a New Drug Application for Yondelis to the U.S. FDA for the Treatment of Advanced Soft Tissue Sarcoma". Madrid. 2014-11-25
Zeltia S.A.. (11/20/14). "Press Release: PharmaMar Results for Antitumoral Compounds and Their Mechanism of Action at EORTC-NCI-AACR Emphasize an Innovative Pipeline of Targeted Ttherapies". Barcelona. 2014-11-20
Zeltia S.A.. (10/25/12). "Press Release: Zeltia Group Operating Revenues up 7%". Madrid. 2012-10-25
Zeltia S.A.. (1/22/13). "Press Release: Genomica AB Starts Its Commercial Activity". Madrid. 2013-01-22
Zeltia S.A.. (1/13/15). "Press Release: PharmaMar Will Start a Phase III Study of PM1183 in Combination with Doxorubicin in Relapsed SCLC". Madrid. 2015-01-13
Zelluna Immunotherapy AS. (11/2/17). "Press Release: Zelluna Immunotherapy Appoints Miguel Forte as Chief Executive Officer". Oslo. 2017-11-02
Zelluna Immunotherapy AS. (10/24/18). "Press Release: Zelluna Immunotherapy Appoints Geir Christian Melen as Chief Financial Officer". Oslo. 2018-10-24
Zellkraftwerk. (1/3/13). "Press Release: Zellkraftwerk Announces Early Access Program. Select Drug Developers to Obtain Pre-release Access to Groundbreaking Cellular Biomarker Discovery Platform". Hannover. 2013-01-03
Zedira GmbH. (9/22/15). "Press Release: Cooperation between Zedira and Cardiff University. Transglutaminase 6 Is the Focus of New Research into Ataxia". 2015-09-22
Zedira GmbH. (7/1/16). "Press Release: Dr. Falk Pharma GmbH and Zedira Enter a Phase 1b Clinical Trial for a Celiac Disease Drug". Freiburg & Darmstadt. 2016-07-01
Zedira GmbH. (6/25/12). "Press Release: Zedira, Dr. Falk Phama and the University of Mainz Hospital, which Together Comprise a Flagship Project of the CI3 Excellence Cluster, Are to Receive Subsidy Funding for Clinical Development of a Celiac Disease Dru 2012-06-25
Zedira GmbH. (5/2/17). "Press Release: Dr. Falk Pharma and Zedira Announce Completion of Phase 1b Clinical Trial of ZED1227 for the Treatment of Celiac Disease and Move on to Proof of Concept Study". Freiburg & Darmstadt. 2017-05-02
Zedira GmbH. (4/26/18). "Press Release: Dr. Falk Pharma and Zedira Announce Start of the Phase 2a Proof of Concept Study of ZED1227 for the Treatment of Celiac Disease". Freiburg & Darmstadt. 2018-04-26
Zedira GmbH. (3/2/15). "Press Release: Dr. Falk Pharma and Zedira Enter Phase I Clinical Trials for a Celiac Disease Drug". Freiburg & Darmstadt. 2015-03-02
Zedira GmbH. (2/3/15). "Press Release: Zedira Receives further Funding to Develop Factor XIIIa-blockers for Safe Anticoagulation". Darmstadt. 2015-02-03
Zedira GmbH. (11/30/16). "Press Release: Zedira Receives Funding by the German Government for the Development of Transglutaminase Inhibitors for the Treatment of Diabetic Nephropathy". Darmstadt. 2016-11-30
Zedira GmbH. (10/20/15). "Press Release: Zedira, Dr. Falk Pharma and the University of Mainz Hospital, which Together Comprise a Flagship Project of the Ci3 Leading-edge Cluster, Are to Receive Additional Subsidy Funding for Clinical Development of a Cel 2015-10-20
Zebra Medical Vision Ltd.. (4/6/15). "Press Release: Zebra Medical Vision Launches the Most Comprehensive Medical Imaging Research Platform Globally". Shefayim. 2016-04-06
Zebra Medical Vision Ltd.. (10/27/17). "Press Release: Zebra Medical Vision to Make AI in Healthcare Accessible & Affordable for All". New York, NY. 2017-10-27
Zealand Pharma A/S. (9/3/13). "Press Release: Zealand Appoints New Chief Scientific Officer. Dr Torsten Hoffmann Joins from Roche". Copenhagen. 2013-09-03
Zealand Pharma A/S. (8/9/17). "Press Release: Zealand Pharma A/S Prices Its Initial Public Offering of American Depositary Shares on The Nasdaq Global Select Market in the United States". Copenhagen. 2017-08-09
Zealand Pharma A/S. (8/28/15). "Press Release: Financial Results in Line with Expectations and Important Progress of the Pipeline". Copenhagen. 2015-08-28
Zealand Pharma A/S. (8/15/17). "Press Release: Overallotment Option of 15% Has Been Exercised". Copenhagen. 2017-08-15
Zealand Pharma A/S. (8/14/17). "Press Release: Zealand Pharma A/S Has Today Registered a Capital Increase of 4,375,000 New Shares and Completed its Initial Public Offering of American Depositary Shares on the Nasdaq Global Select Market in the United Sta 2017-08-14
Zealand Pharma A/S. (7/6/17). "Press Release: Zealand Pharma Files Registration Statement for Proposed Initial Public Offering of ADSs in the U.S.". Copenhagen. 2017-07-06
Zealand Pharma A/S. (7/3/17). "Press Release: Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes". Copenhagen. 2017-07-03
Zealand Pharma A/S. (7/28/14). "Press Release: Zealand and Boehringer Ingelheim Sign Second Collaboration Agreement to Advance Novel Peptide Medicines". Copenhagen & Ingelheim. 2014-07-28
Zealand Pharma A/S. (6/16/11). "Press Release: Zealand Pharma and Boehringer Ingelheim Enter into a License and Collaboration Agreement to Advance Novel Compounds to Treat Type-2 Diabetes and Obesity". Copenhagen & Ingelheim. 2011-06-16
Zealand Pharma A/S. (3/18/09). "Press Release: Zealand Pharma A/S Receives Frost & Sullivan 2008 European Research and Development Award". 2009-03-18
Zealand Pharma A/S. (3/15/13). "Press Release: Zealand Pharma Announces Change in Management". Copenhagen. 2013-03-15
Zealand Pharma A/S. (3/14/13). "Press Release: Zealand Pharma A/S Announces Full Year Results and Annual Report for 2012". Copenhagen. 2013-03-14
Zealand Pharma A/S. (3/14/13). "Press Release: Zealand Launches New Corporate Branding Platform and Logo". Copenhagen. 2013-03-14
Zealand Pharma A/S. (2/3/09). "Press Release: FDA Has Approved Zealand Pharma’s Investigative New Drug Application (IND) for ZP1848 to Be Administered in Humans. ZP1848 Is Developed for the Prevention and Treatment of Crohn’s Disease". 2009-02-03
Zealand Pharma A/S. (12/30/11). "Press Release: Zealand Pharma Receives Milestone Payments. EUR 3 Million Received Under the License Agreement for Elsiglutide, a Peptide Drug in Development for the Treatment of Chemotherapy Induced Diarrhea". Copenhagen. 2011-12-30
Zealand Pharma A/S. (12/3/15). "Press Release: Zealand Strengthens Its Senior Management Team with the Appointment of Carlos de Sousa as Chief Business Officer". Copenhagen. 2015-12-03
Zealand Pharma A/S. (12/18/15). "Press Release: Zealand to Present at 34th Annual J.P. Morgan Healthcare Conference on 14 January 2016". Copenhagen. 2015-12-18
Zealand Pharma A/S. (12/15/14). "Press Release: Zealand’s Chief Business Officer Steps Down". Copenhagen. 2014-12-15
Zealand Pharma A/S. (12/12/14). "Press Release: Zealand Raises USD 50 / DKK 300 Million in a Royalty Bond Financing. Unlocking Part of the Value of Lixisenatide (Lyxumia®) to Accelerate and Broaden the Proprietary Pipeline". Copenhagen. 2014-12-12
Zealand Pharma A/S. (12/12/11). "Press Release: Zealand Pharma Issues New Shares in Connection with Warrants Exercise and Announces Trading in the Company’s Shares and Related Securities by Executives and Their Related Parties". Copenhagen. 2011-12-12
Zealand Pharma A/S. (12/12/11). "Press Release: Zealand Pharma Announces Registration of Capital Increase and New Articles of Association Following Warrant Exercise". Copenhagen. 2011-12-12
Zealand Pharma A/S. (11/3/11). "Press Release: Zealand Pharma Announces that a European Regulatory Application Has Been Submitted for Lyxumia (lixisenatide) by Its Partner Sanofi, as a Novel Once-daily GLP-1 Agonist for Type-2 Diabetes". Copenhagen. 2011-11-03
Zealand Pharma A/S. (11/3/10). "Press Release: Zealand Pharma Publishes Prospectus and Sets Indicative Price Range for Initial Public Offering". 2010-11-03
Zealand Pharma A/S. (11/15/13). "Press Release: Interim Report for the First Nine Months of 2013 (un-audited)". Copenhagen. 2013-11-15
Zealand Pharma A/S. (10/9/15). "Press Release: Zealand Meets Development Milestone in Collaboration with Boehringer Ingelheim". Copenhagen. 2015-10-09
Zealand Pharma A/S. (10/22/15). "Press Release: Zealand to Attend Three International Investor Healthcare Conferences and Host Capital Markets Days in November". Copenhagen. 2015-10-22
Zealand Pharma A/S. (10/15/10). "Press Release: Positive Phase I Data for ZP1848 in Crohn’s Disease. Study Findings Demonstrate Significant Increase in Citrulline Levels Indicating Enhanced Gut Function". Copenhagen. 2010-10-15
Zealand Pharma A/S. (10/1/18). "Press Release: Zealand Pharma Expands Leadership Team and Appoints Marino Garcia as Senior Vice President of Corporate & Business Development". Copenhagen. 2018-10-01
Zealand Pharma A/S. (1/4/13). "Press Release: Zealand Pharma Appoints New Chief Operating Officer. Agneta Svedberg Named as Successor to Senior Vice President and Chief Operating Officer, John Hyttel, Who Is Retiring". Copenhagen. 2013-01-04
1 2 3 ... 167 168 169  next pagenext page



Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

» top